• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

IVF Hartmann Holding AG

  • ID: 644560
  • April 2015
  • 56 Pages
  • Wright Investors Service

A textual analysis of the financial results for IVF Hartmann Holding AG compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up to 10-year history of sales, earnings, dividends and security pricing. A business description of the company, including contact information, senior officers and Wright Quality Rating analyses is also provided.

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio tables (Accounting, Asset Utilization, Employee Efficiency, Fixed Charges Coverage, Leverage Analysis, Liquidity Analysis, Per-share Data and Profitability Analysis) and proprietary Wright Quality Rating analyses tables. The Wright Quality Rating, a measure of corporate risk, examines the liquidity of the stock, financial strength, profitability and corporate growth characteristics of IVF Hartmann Holding AG. There is a textual review of the financial results of IVF Hartmann Holding AG versus Coltene Holding AG, Lifewatch AG and Comet Holding AG. The comparative analysis of these companies compares Sales (sales, sales growth and sales READ MORE >

Note: Product cover images may vary from those shown

Company Fundamentals
- Company Profile
- Comparative Business Analysis
- Summary Analysis per Share
- Sales Analysis
- Price Analysis
- Earnings and Dividends Analysis

Financial Statement Analyses
- Balance Sheet - Common Size
- Balance Sheet - Year-Year Percent Change
- Balance Sheet - Five-Year Averages
- Income Statement - Common Size
- Income Statement - Year-Year Percent Change
- Income Statement - Five-Year Averages
- Sources of Capital

Financial Ratio Analyses
- Accounting Ratios
- Asset Utilization
- Employee Efficiency
- Fixed Charges Coverage
- Leverage Analysis
- Liquidity Analysis
- Per-Share Data
- Profitability Analysis

Wright Quality Rating Analyses
- Investment Acceptance
- Financial Strength
- Profitability and Stability
- Corporate Growth

Note: Product cover images may vary from those shown

Switzerland

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown

RELATED PRODUCTS

  • IVF Hartmann Holding AG: Company Capsule - Product Thumbnail Image IVF Hartmann Holding AG: Company Capsule

    IVF Hartmann Holding AG: Company Capsule

    • Language: English
    • Published: November 2012
    FROM
  • IVF Hartmann Acquisition Manual - Product Thumbnail Image IVF Hartmann Acquisition Manual

    IVF Hartmann Acquisition Manual

    • Language: English
    • Published: May 2015
  • Paul Hartmann AG (PHH2) - Financial and Strategic SWOT Analysis Review - Product Thumbnail Image
    FROM
  • Analysis of Adidas AG - Product Thumbnail Image Analysis of Adidas AG

    Analysis of Adidas AG

    • Language: English
    • 80 Pages
    • Published: January 2015
    • Region: Global
    FROM
  • Monash IVF Group Ltd - Product Thumbnail Image Monash IVF Group Ltd

    Monash IVF Group Ltd

    • Language: English
    • 53 Pages
    • Published: April 2015
    FROM
  • Lifewatch AG - Product Thumbnail Image

    Lifewatch AG

    • Language: English
    • 56 Pages
    • Published: April 2015
    FROM
  • Avon Rubber p.l.c. - Product Thumbnail Image

    Avon Rubber p.l.c.

    • Language: English
    • 55 Pages
    • Published: April 2015
    FROM
  • Brodrene Hartmann AS - Product Thumbnail Image

    Brodrene Hartmann AS

    • Language: English
    • 55 Pages
    • Published: March 2015
    FROM
  • Coltene Holding AG - Product Thumbnail Image

    Coltene Holding AG

    • Language: English
    • 56 Pages
    • Published: April 2015
    FROM
  • Paul Hartmann AG - Product Thumbnail Image

    Paul Hartmann AG

    • Language: English
    • 56 Pages
    • Published: April 2015
    FROM

Our Clients

Fluidigm Corporation Apple, Inc. CEVA Santé Animale Abbott Laboratories Ltd. Merck Group Allergan Inc. Pfizer, Inc.